Healthy Living/WellnessChina Rejects Patent Application Of Gilead For $1,000 A Day Hepatitis C Drug Sovaldi China rejected a patent application of Gilead Sciences for its hepatitis C drug Sovaldi. Advocacy group I-MAK said that the decision could pave way for other countries to reject the company's application as well.by Rhodi Lee
Healthy Living/WellnessTofu Addict Shocks Doctors With 420 Kidney Stones Removed During Two-Hour Operationby Rina Marie Doctor
ScienceNeil deGrasse Tyson Thinks Militarized US vs. China Space Race Will Spark Innovationby Rhodi Lee